I, Nicole McLay, as delegate of the Secretary of the Department of Health, make the following permission.
Dated 2 February 2022
Regulatory Compliance Branch
Health Products Regulation Group
Department of Health
Schedule 1 - Permission: restricted representations
This instrument is the Therapeutic Goods (Restricted Representations - COVID 19 Rapid Antigen Tests) Permission (No. 2) 2022.
- Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.
|Column 1||Column 2||Column 3|
|1. The whole of this instrument||The day after this instrument is made.||3 February 2022|
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
- Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.
This instrument is made under section 42DK of the Therapeutic Goods Act 1989.
Note: A number of expressions used in this instrument are defined in subsection 3(1) of the Act, including the following:
(b) health practitioner;
(c) included in the Register;
(f) therapeutic goods;
(g) Therapeutic Goods Advertising Code.
In this instrument:
Act means Therapeutic Goods Act 1989.
Class 1 IVD medical device has the same meaning as in the Medical Devices Regulations.
Class 3 IVD medical device has the same meaning as in the Medical Devices Regulations.
instructions for use has the same meaning as in the Medical Devices Regulations.
IVD medical device has the same meaning as in the Medical Devices Regulations.
IVD medical device for self-testing has the same meaning as in the Medical Devices Regulations.
Medical Devices Regulations means the Therapeutic Goods (Medical Devices) Regulations 2002.
point of care testing has the same meaning as in the Medical Devices Regulations.
prominently displayed or communicated has the same meaning as in the Therapeutic Goods Advertising Code.
relevant practitioner means:
- a health practitioner; or
- a person registered under a law of a state or territory to practice paramedicine.
Note: The term health practitioner is defined in subsection 3(1) of the Act to mean a person who is registered or licenced under a law of a state or territory to practice in certain health professions specified in the definition, including medicine.
restricted representation means a representation referred to in section 42DD of the Act.
SARS-CoV-2 (COVID-19) means the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes the disease COVID-19.
serious, in relation to a form of a disease, condition or ailment, has the same meaning as in the Therapeutic Goods Advertising Code.
specified goods means a COVID-19 rapid antigen test kit that is:
- included in the Register; and
- classified as a Class 3 IVD medical device; and
may (or may not) be supplied for use in conjunction with an instrument or analyser that is a Class 1 IVD medical device.
Note: The specified goods may be an IVD medical device for self-testing, or an IVD medical device for point of care testing by a relevant practitioner, or both.
For subsection 42DK(1) of the Act, in relation to each item mentioned in the table in Schedule 1, the representations specified in column 2 are permitted to be used in the advertisements specified in column 3, about the therapeutic goods specified in column 4, subject to the conditions (if any) specified in column 5.
This instrument does not apply to an advertisement made in accordance with the Therapeutic Goods (Restricted Representations - Government Health Campaigns) (COVID-19 Tests) Permission 2022.
Note: The Therapeutic Goods (Restricted Representations—Government Health Campaigns) (COVID-19 Tests) Permission 2022 deals with Commonwealth and state or territory health campaigns relating to COVID-19 testing, and is published at www.tga.gov.au.
Each instrument that is specified in Schedule 2 is repealed as set out in the applicable items in that Schedule.
Schedule 1 - Permission: restricted representation
Note: See section 5.
|Column 1||Column 2||Column 3||Column 4||Column 5|
|Item||Restricted representation||Advertisement||Therapeutic goods||Conditions|
a representation to the effect, expressly or by implication, that the therapeutic goods may be used to detect possible infection with SARS-CoV-2 (COVID-19), including a representation that is contained within the name of the goods
an advertisement about the therapeutic goods including, but not limited to, an advertisement that is:
all of the following:
a representation that refers, expressly or by implication, to a serious form of disease, condition or ailment, where the reference is necessary to provide information about the proper use of the therapeutic goods
an advertisement made in accordance with item 1 that includes instructions for use relating to the therapeutic goods (including but not limited to instructions in written, graphical, pictorial or video form)
Note: The advertisements mentioned in the table must comply with the Act and the Therapeutic Goods Advertising Code, including requirements relating to the accuracy of the advertisements.
Schedule 2 - Repeals
Note: See section 6.
Therapeutic Goods (Restricted Representations - COVID-19 Rapid Antigen Tests) Permission 2022
1 The whole of the instrument
Repeal the instrument.